Life Edit Therapeutics
BiotechnologyView the employees at
Life Edit Therapeutics-
Drew Kelso Senior Scientist at Life Edit Therapeutics
-
Raleigh-Durham-Chapel Hill Area
-
Top 5%
Skylar Ashforth Undergraduate Genetics Student at North Carolina State University-
Raleigh, North Carolina, United States
-
Rising Star
James Thomas Scientist II at Life Edit Therapeutics-
Durham, North Carolina, United States
-
Top 10%
K. Tyler McCullough Preclinical Development-
Raleigh-Durham-Chapel Hill Area
-
Top 5%
Bikash Shakya, Ph.D. Scientist, Technology Development at Life Edit Therapeutics-
Top 10%
Overview
Life Edit, an ElevateBio company, is a next-generation genome editing company that has built a highly innovative platform with one of the world’s largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The platform allows Life Edit to target any genomic sequence and develop novel human therapeutics for the most challenging genetic diseases by enabling ex vivo engineering for cell therapies and regenerative medicines and in vivo delivery of gene therapies. In addition to developing its own pipeline of cell and gene therapies, Life Edit Therapeutics will continue to strengthen its platform of genome-editing enzymes, provide gene-editing expertise to strategic partners, and form other third-party partnerships to discover and develop new therapies.
-